GE Healthcare, the medical device subsidiary of General Electric will seek to increase its China revenues by expanding beyond top tier markets. The company plans to introduce 32 new products in China over the next five years, 70% of which will be aimed at grassroots institutions. GE wants to generate 50% of its China revenues from these institutions by 2017, up from less than 20% at present. More details....

Stock Symbol:  (NYSE: GE)